| __timestamp | TG Therapeutics, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 24518692 | 7751000 |
| Thursday, January 1, 2015 | 19886580 | 10251000 |
| Friday, January 1, 2016 | 12631689 | 9575000 |
| Sunday, January 1, 2017 | 21977998 | 10912000 |
| Monday, January 1, 2018 | 20759000 | 11049000 |
| Tuesday, January 1, 2019 | 20838000 | 11646000 |
| Wednesday, January 1, 2020 | 121812000 | 13265000 |
| Friday, January 1, 2021 | 152137000 | 25805000 |
| Saturday, January 1, 2022 | 83231000 | 35182000 |
| Sunday, January 1, 2023 | 122706000 | 94999000 |
Data in motion
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of TG Therapeutics, Inc. and Viridian Therapeutics, Inc. over the past decade. From 2014 to 2023, TG Therapeutics saw a dramatic increase in SG&A expenses, peaking in 2021 with a 1,200% rise from 2014 levels. In contrast, Viridian Therapeutics experienced a steadier growth, with expenses increasing by approximately 1,200% over the same period. Notably, 2023 marked a significant year for Viridian, with expenses reaching nearly 95% of TG Therapeutics' peak in 2021. This trend highlights the strategic financial maneuvers each company has undertaken to navigate the biotech landscape. Understanding these patterns offers valuable insights into their operational strategies and market positioning.
Selling, General, and Administrative Costs: AstraZeneca PLC vs Viridian Therapeutics, Inc.
Comparing SG&A Expenses: Amgen Inc. vs TG Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Zoetis Inc. vs TG Therapeutics, Inc.
Selling, General, and Administrative Costs: Alnylam Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
Breaking Down SG&A Expenses: Summit Therapeutics Inc. vs TG Therapeutics, Inc.
Madrigal Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Grifols, S.A. vs TG Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Cytokinetics, Incorporated or TG Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and Veracyte, Inc.
Rhythm Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? ImmunityBio, Inc. or Viridian Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.